Back to search

Article

Single-Cell Analysis Reveals Inflammatory–Immunosuppressive Niches in Daratumumab-Resistant Primary AL Amyloidosis

2026-03-31

Abstract excerpt

<h4>ABSTRACT</h4> Primary light-chain amyloidosis (pAL) is caused by plasma cell (PC) clones that secrete misfolded free light chains that deposit. Anti-CD38 antibody daratumumab is the first-line therapy, while ∼10–30% of patients exhibit suboptimal responses (<very good partial response, VGPR), and baseline predictors and resistance mechanisms remain under investigation. We generated a single-cell bone marrow a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1c52d94b-9869-5ba9-ad03-eb88bbde7350
DOI
10.64898/2026.03.28.26349317
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Single-Cell Analysis Reveals Inflammatory–Immunosuppressive Niches in Daratumumab-Resistant Primary AL AmyloidosisDOI 10.64898/2026.03.28.26349317
Select a neighboring publication to make it the new centre.